Clinical Trial Update: A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a radiolabeled 14C-Bleximenib in patients with acute leukemia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia

Drugs mentioned

• 14C-Bleximenib (Radiolabeled) (14C-Bleximenib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Lymphoblastic Leukemia, Acute Leukemias | Phase 1 | Status: RECRUITING